Ten-year follow-up of helium ion therapy for uveal melanoma

American Journal of Ophthalmology

Volumn 125, Issue 1, 1998, Pages 81-89

  Char, Devron H ^a,b   Kroll, Stewart M ^a   Castro, Joseph ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Box 0730 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELIUM;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STATISTICS; CATARACT; ENUCLEATION; FEMALE; HELIUM ION RADIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEOVASCULAR GLAUCOMA; PRIORITY JOURNAL; RADIATION DOSE; RETINA FOVEA; RETINA MACULA CYSTOID EDEMA; RETINOPATHY; TREATMENT OUTCOME; UVEA MELANOMA; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 0031984553     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(99)80238-4     Document Type: Article

References (37)

1. 1. Char DH. Clinical ocular oncology, 2nd edition. Philadelphia: Lippincott-Raven, 1997:89-170.
2. 2. Stallard HB. Malignant melanoblastoma of the choroid. Bibl Ophthalmol 1968;75:16-38.
3. 3. Davidorf FH, Makley TA, Lang JR. Radiotherapy of malignant melanoma of the choroid. Trans Am Acad Ophthalmol Otolaryngol 1976;81:849-861.
4. 4. Packer S, Rotman M. Radiotherapy of choroidal melanoma with iodine-125. Ophthalmology 1980;87:582-590.
5. 5. Egan KM, Gragoudas ES, Seddon JM, et al. The risk of enucleation after proton beam irradiation of uveal melanoma. Ophthalmology 1989;96:1377-1383.
6. 6. Zografos L, Bercher L, Egger E, et al. Treatment of eye tumors by accelerated proton beams: 7 years' experience. Klin Monatsbl Augenheilkd 1992;200:431-435.
7. 7. Finger PT, Buffa A, Misra S, Berson A, Bosworth JL, Bikram B. Palladium 103 plaque radiotherapy for uveal melanoma: clinical experience. Ophthalmology 1994;101:256-263.
8. 125I brachytherapy versus helium ion irradiation. Ophthalmology 1989;96:1708-1715.
9. 125I) plaque treatment of uveal melanoma. Int J Radiat Oncol Biol Phys 1993;26: 613-618.
10. 10. Gragoudas ES, Seddon JM, Egan K, et al. Long-term results of proton beam irradiated uveal melanomas. Ophthalmology 1987;94:349-353.
11. 11. Char DH, Kroll SM, Miller TA, Castro J, Quivey JM. Irradiated uveal melanomas: cytopathologic correlation with prognosis. Am J Ophthalmol 1996;122:509-513.
12. 12. Summanen P, Immonen I, Heikkonen J, Tommila P, Laatikainen L, Tarkkanen A. Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy. Ophthalmic Surg 1993;24:82-90.
13. 13. Duker JS, Augsburger JJ, Shields JA. Noncontiguous local recurrence of posterior uveal melanoma after cobalt 60 episcleral plaque therapy. Arch Ophthalmol 1989;107: 1019-1022.
14. 14. Guthoff R, Haase J, von Domarus D, Draeger J, Lauritzen K. Das Regressionsveralten des adehautmelanoms nach strahlentherapie: ein neuer prognostischer paramater? Klin Monatsbl Augenheilkd 1990;196:6-10.
15. 60Co episcleral plaque therapy. Ophthalmology 1989; 96:382-388.
16. 16. Char DH. Metastatic choroidal melanoma. Am J Ophthalmol 1978;86:76-80.
17. 17. Char DH, Castro JR, Kroll SM, Irvine AR, Quivey JM, Stone RD. Five-year follow-up of helium-ion therapy for uveal melanoma. Arch Ophthalmol 1990;108:209-214.
18. 18. Meecham WJ, Char DH, Kroll SM, Castro JR, Blakely EA. Anterior segment complications after helium ion radiation therapy for uveal melanoma: radiation cataract. Arch Ophthalmol 1994;112:197-203.
19. 19. Char DH, Saunders W, Castro JR, et al. Helium ion therapy for choroidal melanoma. Ophthalmology 1983;90: 1219-1225.
20. 20. Char DH, Quivey JM, Castro J, Kroll SM, Phillips TA. Helium ions versus iodine-125 brachytherapy in the management of uveal melanoma: a prospective randomized dynamically balanced trial. Ophthalmology 1993;100:1547-1554.
21. 21. Char DH, Stone RD, Irvine AR, et al. Diagnostic modalities in choroidal melanoma. Am J Ophthalmol 1980;89: 223-230.
22. 22. Anderson PK, Borgan O, Gill RD, Keiding N. Statistical models based on counting processes. New York: Springer-Verlag, 1993.
23. 23. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481, 562-563.
24. 24. Cox DR. Regression models and life-tables (with discussion). Journal of the Royal Statistical Society B 1972;34:187-220.
25. 25. Benichou J, Gail MH. Estimates of absolute cause-specific risk in cohort studies. Biometrics 1990;46:813-826.
26. 26. Berry G. The analysis of mortality by the subject-years method. Biometrics 1983;39:173-184.
27. 27. National Center for Health Statistics. Vital statistics of the United States, 1989. Volume II. Section 6: life tables. DHHS publication no. (PHS) 92-1104. Washington, DC: Department of Health and Human Services, 1989.
28. 28. Gragoudas ES, Egan KM, Seddon JM, Walsh SM, Munzenrider JE. Intraocular recurrence of uveal melanoma after proton beam irradiation. Ophthalmology 1992;99: 760-766.
29. 125I plaque therapy for uveal melanoma: analysis of the impact of time and dose factors on local control. Cancer 1996;77: 2356-2362.
30. 30. Mameghan H, Fisher R, Mameghan J, Brooks S. Results of external beam radiotherapy in 448 patients with clinically localized adenocarcinoma of the prostate. Aust N Z J Surg 1994;64:389-394.
31. 31. Moreno JG, Ahlering TE. Late local complications after definitive radiotherapy for prostatic adenocarcinoma. J Urol 1992;147:926-928.
32. 32. Vrabec TR, Augsburger JJ, Gamel JW, Brady LW, Hernandez C, Woodleight R. Impact of local tumor relapse on patient survival after cobalt 60 plaque radiotherapy. Ophthalmology 1991;98:984-988.
33. 33. Guyer DR, Mukai S, Egan KM, Seddon JM, Walsh SM, Gragoudas ES. Radiation maculopathy after proton beam irradiation for choroidal melanoma. Ophthalmology 1992; 99:1278-1285.
34. 34. Kroll S, Char DH, Quivey J, Castro J. Tumor-related mortality following radiotherapy for uveal melanomas. Ophthalmology, In press.
35. 35. Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Milion RR. Radiation retinopathy after external-beam irradiation: analysis of time dose factors. Int J Radiat Oncol Biol Phys 1994;30:765-773.
36. 36. Gragoudas ES, Egan KM, Walsh SM, Regan S, Munzenrider JE, Taratuta V. Lens changes after proton beam irradiation for uveal melanoma. Am J Ophthalmol 1995;119:157-164.
37. 37. Kleineidam M, Augsburger JJ, Hernandez C, Glennon P, Bardy LW. Cataractogenesis after cobalt-60 eye plaque radiotherapy. Int J Radiat Oncol Biol Phys 1993;26:625-630.